2022 annual financial data
INmune Bio 2022 Net margin
Direct answer
Net margin was -7,659.63%.
Operating income was -25,951,000 USD and net income was -28,647,000 USD.
Operating cash flow was -22,686,000 USD.
Get free INmune Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 374,000 USD
- Operating income
- -25,951,000 USD
- Net income
- -28,647,000 USD
- Operating cash flow
- -22,686,000 USD